Szela Mary T's Form 4 filing
TriSalus Life Sciences, Inc. (TLSI) · filed Jan 29, 2025
- Accession no.
- 0001415889-25-002292
- Filed
- Jan 29, 2025
- Trade date
- Jan 27-28, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $50.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Szela Mary TCIK 0001410289 | Director, Officer (CEO AND PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Common Stock | AGrant or awardAcquired | +40,000 | $0.00 | $0 | 424,677 | Direct | |
| Jan 27, 2025 | Common Stock | PPurchaseAcquired | +4,826 | $5.42 | +$26,156.92 | 429,503 | Direct | |
| Jan 28, 2025 | Common Stock | PPurchaseAcquired | +4,716 | $5.12 | +$24,145.92 | 434,219 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Common Stock | AGrant or awardAcquired | +240,000 | $0.00 | $0 | 240,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.